Back

How good is pulmonary vein isolation in atrial fibrillation with heart failure?

29 August 2022 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: The management challenge of atrial fibrillation in HFrEF and HFpEF Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

4 More presentations in this session

Presentation thumbnail
Atrial fibrillation and heart failure: epidemiology, risk factors and prevention.
Professor L. Kober (Copenhagen, DK)
Slides Video
Presentation thumbnail
Rate control first for most atrial fibrillation patients: beta-blocker and/or digitalis?
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Atrioventricular node ablation and CRT is the future.
Professor G. Hindricks (Berlin, DE)
Slides Video
Presentation thumbnail
The management challenge of atrial fibrillation in HFrEF and HFpEF – discussion.
Doctor E. O'Meara (Montreal, CA)
Slides Video

Access the full session

Session thumbnail
The management challenge of atrial fibrillation in HFrEF and HFpEF
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 09:06 CET
You may be interested in
thumbnail
Congress Session
Optimising management of atrial fibrillation and heart failure
28 August 2022
thumbnail
Congress Presentation
Ablation of atrial fibrillation
17 May 2025
thumbnail
Congress Presentation
Heart failure (HF) and atrial fibrillation (AF) in the guidelines: time to harmonize?
23 May 2022
thumbnail
Congress Presentation
Atrial fibrillation ablation in heart failure: where are we?
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources